Jubilant Cadista recalls 150mg Lamotrigine tablets with silica granules from desiccant packs. Foreign substance may cause injury. Check lot numbers 19P0437 & 19P0438.
“Jubilant Cadista Lamotrigine Tablets Recall: Foreign Silica Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37102-jubilant-cadista-lamotrigine-tablets-recall-foreign-silica-risk. Based on FDA recall #D-1281-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1281-2020%22&limit=1).
Jubilant Cadista Pharmaceuticals, Inc. recalled Lamotrigine Tablets, USP, 150 mg from a 20,000-count bulk container due to foreign silica granules, the FDA said on May 26, 2020. The voluntary Class III recall affected 1,313,333 tablets distributed in Tennessee.
The recall cites the presence of foreign substances visually consistent with silica granules from desiccant packs used during storage. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Jubilant Cadista Pharmaceuticals, Inc. has had 24 other recalls since February 11, 2013. Recent brand recalls include Prochlorperazine Tablets on December 27, 2022, and Irbesartan tablets on July 18, 2022. Other recent recalls of similar products include Bionpharma Divalproex Tablets (June 26, 2026), Graviti Furosemide Tablets (January 10, 2026), and Guardian Drug CAREone Calcium Antacid (May 28, 2026).
How to tell if you have this one
Check for Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk containers. Look for lot numbers 19P0437 or 19P0438 on the packaging.
Brand
Jubilant Cadista
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Lot Number
Look for lot numbers 19P0437 or 19P0438 on the packaging of the Lamotrigine tablets.
Where it went and when
Where it was distributed
Distributed in Tennessee.
Listed by the agency
Not listed
FDA distribution: “TN” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Tennessee.
Recall timeline
FDA terminated this recall 2.5 years after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1281-2020 (May 26, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1281-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.